Autopsy report · NCT01471054

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

“Could not enroll enough patients.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 5 months before it started.
• Ran for about 1 year 3 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 3 years 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Arman Mashayekhi

Sponsor type

University, hospital or other

Conditions

Macular Edema; Cystoid Macular Edema; Uveal Melanoma; Radiation Maculopathy; Radiation Retinopathy

Interventions

Ozurdex; Bevacizumab

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
  “no enough enrolled patients” (84% match in meaning)
• Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
  “Unable to enroll appropriate patients” (82% match in meaning)
• Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
  “Unable to enroll patients.” (82% match in meaning)
• Wellness Initiative at New York University
  “Due to inability to enroll patients” (82% match in meaning)
• The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision
  “Unable to enroll more patients” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.